Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
Harvard Business School
Express Scripts
Merck
Cerilliant
Johnson and Johnson
Deloitte
Queensland Health
US Department of Justice

Generated: January 21, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Etrolizumab

« Back to Dashboard

US Patents for Etrolizumab

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Etrolizumab ➤ Try a Free Trial Nucleic acid comprising or coding for a histone stem-loop and a poly(A) sequence or a polyadenylation signal for increasing the expression of an encoded therapeutic protein CureVac AG (Tubingen, DE) ➤ Try a Free Trial
Etrolizumab ➤ Try a Free Trial Nucleic acid comprising or coding for a histone stem-loop and a poly(A) sequence or a polyadenylation signal for increasing the expression of an encoded therapeutic protein CureVac AG (Tubingen, DE) ➤ Try a Free Trial
Etrolizumab ➤ Try a Free Trial Methods for diagnosing and treating inflammatory bowel disease Genentech, Inc. (South San Francisco, CA) ➤ Try a Free Trial
Drugname Patent Number Patent Title Patent Assignee Estimated Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

International Patents for Etrolizumab

Drugname Country Document Number Estimated Expiration Related US Patent
Etrolizumab Australia 2013220749 2032-02-15 ➤ Try a Free Trial
Etrolizumab Brazil 112014019627 2032-02-15 ➤ Try a Free Trial
Etrolizumab Canada 2862476 2032-02-15 ➤ Try a Free Trial
Etrolizumab China 104114705 2032-02-15 ➤ Try a Free Trial
Etrolizumab European Patent Office 2814963 2032-02-15 ➤ Try a Free Trial
Etrolizumab India 5670DEN2014 2032-02-15 ➤ Try a Free Trial
Drugname Country Document Number Estimated Expiration Related US Patent

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Merck
Argus Health
Queensland Health
Cerilliant
US Army
Mallinckrodt
Fish and Richardson
Farmers Insurance
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.